Evidence map›Paper›PMID 41556454›Full record

ArticleMacromolecular rapid communications2026

Orthogonal Staggered Alignment of Molecular Chains in Aramid Whiskers: A Game-Changer for Sustainable, High-Performance Composites.

Satoshi Okamoto, Justin Llandro, Andrew Gibbons, Mohamed Arfaoui, Daisuke Hashizume, Junji Watanabe

Abstract read
In one paragraph

Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Satoshi OkamotoRIKEN Baton Zone Program TRIP Headquarters, Wako, Saitama, Japan.ORCID https://orcid.org/0009-0008-3901-6882
Justin LlandroRIKEN Baton Zone Program TRIP Headquarters, Wako, Saitama, Japan.
Andrew GibbonsRIKEN Baton Zone Program TRIP Headquarters, Wako, Saitama, Japan.
Mohamed ArfaouiRIKEN Center for Emergent Matter Science (CEMS), Wako, Saitama, Japan.
Daisuke HashizumeRIKEN Center for Emergent Matter Science (CEMS), Wako, Saitama, Japan.
Junji WatanabeLaboratory for Future Interdisciplinary Research of Science and Technology, Institute of Science Tokyo, Yokohama, Kanagawa, Japan.

Funding

Sumitomo Chemical Co., Ltd.
6 · The paper itself

Abstract

We report the first discovery of polymer single crystal whiskers with a fundamentally unprecedented architecture: prismatic poly(p-benzamide) (PBA) whiskers with practical dimensions (∼17 µm length, ∼1 µm width, ∼0.5 µm thickness). Within these whiskers, polymer chains are oriented perpendicular to the long axis while maintaining high crystallinity. This morphology diverges from conventional lamellar structures, representing a new class of staggered polymer crystalline architecture where adjacent chains interpenetrate without layered periodicity. The configuration exposes chain ends at whisker surfaces, significantly enhancing dispersibility in organic solvents and polymer matrices due to the high-energy surface. Composites incorporating these whiskers exhibit uniform microstructures, exceptional thermal stability, and high modulus. PBA whiskers offer a lightweight, organic alternative to traditional inorganic fillers. These findings not only introduce a sustainable strategy but also redefine structural design principles in polymer crystallography for high-performance materials via self-organization pathways.

Indexed as

BenzamidesPolymersCrystallizationMolecular StructureSurface PropertiesBenzamidesPolymersenhanced surface energyhigh‐performance compositesorthogonal chain alignmentpolymer single crystal whiskerstaggered crystalline architecture

Identifiers

PMID41556454
PMCPMC12922731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.